Parametrica Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Parametrica Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-928	Closed	-$462K	–	78
2022 Q2	$462K	Buy	928 +404	+77%	+$210K	0.5%	43
2022 Q1	$296K	Buy	+524	New	+$316K	0.22%	122
2020 Q4	–	Sell	-435	Closed	-$224K	–	162
2020 Q3	$224K	Buy	+435	New	+$220K	0.42%	71
2019 Q2	–	Sell	-1,079	Closed	-$330K	–	16
2019 Q1	$330K	Buy	+1,079	New	+$291K	0.7%	38
2017 Q3	–	Sell	-1,288	Closed	-$291K	–	352
2017 Q2	$291K	Sell	1,288 -592	-31%	-$129K	0.27%	141
2017 Q1	$375K	Buy	1,880 +606	+48%	+$117K	0.39%	85
2016 Q4	$232K	Buy	+1,274	New	+$217K	0.23%	156
2016 Q3	–	Sell	-2,669	Closed	-$382K	–	140
2016 Q2	$382K	Buy	+2,669	New	+$381K	0.57%	43

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Parametrica Management's BIO Position: Q3 2022 in Review

Parametrica Management sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2022, closing a stake of 928 shares — an estimated $462K sold.

Parametrica Management first reported a position in BIO in Q2 2016 and held it in 8 quarters. The position peaked at $462K in Q2 2022. 484 funds tracked by Wall St. Rank hold BIO as of Q3 2022.

Parametrica Management reported no remaining Bio-Rad Laboratories Class A position as of Q3 2022 after selling out during the quarter.
Parametrica Management sold 928 Bio-Rad Laboratories Class A shares in Q3 2022, an estimated $462K.
Parametrica Management first reported a position in Bio-Rad Laboratories Class A in Q2 2016 and held it in 8 quarters.
Parametrica Management's Bio-Rad Laboratories Class A position peaked at $462K in Q2 2022.
484 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2022.

Based on Parametrica Management's 13F filing for Q3 2022, filed 3 Nov 2022.